BioCentury
ARTICLE | Clinical News

Zyprexa olanzapine: Post-marketing study data

September 22, 2008 7:00 AM UTC

NIH said data from the double-blind, U.S. TEOSS study in 116 schizophrenics 8-19 years old showed that second-generation antipsychotics olanzapine and risperidone were no better than molindone plus be...